XIFAXAN®

XIFAXAN® 550 mg

 

PRESCRIPTION MEDICINE

 

XIFAXAN® 550 mg is Rifaximin.  XIFAXAN®  550 mg is indicated for “Prevention of the recurrence of hepatic encephalopathy where other treatments have failed or are contraindicated”.

 

 Consumer Medicine Information

 

 Product Information

 

 

 

XIFAXAN® 200 mg

 

PRESCRIPTION MEDICINE

 

XIFAXAN® 200 mg (Rifaximin) is indicated for the treatment of patients (≥ 12 years of age) with travellers’ diarrhoea caused by non-invasive strains of Escherichia coli.

 

 Consumer Medicine Information

 

 Product Information

 

 

Product under licence from Alfasigma S.p.A.  XIFAXAN is a registered trademark of the Alfasigma group of companies, licensed to the Norgine group of companies.

 

ANZ/COR/0814/0002a(1).  Date of Preparation: September 2018